In collaboration with a strategic partner, we are developing an FPF imager for in vivo ocular imaging of small laboratory animals. This device will be optimized for research studies, allowing investigators to assess ocular metabolic health without sacrificing the animals.

The OcuMet Mariner will enable the monitoring of the effects of novel therapeutics in animal models.